Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Leiomyoma × Indocyanine Green × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Myofibroma 1 Leiomyoma 1 Endometriosis 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Carcinoma, Ductal 1 Bone Neoplasms 1 Adenomyosis 1

Interventions

carboprost tromethamine 1 Triamcinolone Acetonide 1 Triamcinolone 1 Radiofrequency Ablation 1 Iohexol 1 Indocyanine Green 1 High-Energy Shock Waves 1 Bupivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927651 2023-04-18

ICG to Assess Ovarian Perfusion

Northwestern University

Phase EARLY_PHASE1 Completed

Endometriosis, Leiomyoma, Myofibroma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡